Phibro Animal Health (NASDAQ:PAHC) Stock Rating Lowered by StockNews.com

StockNews.com downgraded shares of Phibro Animal Health (NASDAQ:PAHC) from a buy rating to a hold rating in a research note issued to investors on Tuesday morning.

Other equities analysts have also recently issued reports about the stock. Barclays lifted their target price on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a report on Monday, February 10th. Morgan Stanley lifted their price objective on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 17th. Two equities research analysts have rated the stock with a sell rating and three have assigned a hold rating to the company’s stock. According to data from MarketBeat.com, Phibro Animal Health has a consensus rating of “Hold” and a consensus price target of $21.00.

Phibro Animal Health Price Performance

Shares of PAHC opened at $21.68 on Tuesday. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. Phibro Animal Health has a 1-year low of $12.17 and a 1-year high of $26.55. The stock has a market cap of $878.11 million, a PE ratio of 45.17, a price-to-earnings-growth ratio of 0.45 and a beta of 0.58. The firm has a fifty day moving average price of $22.77 and a 200 day moving average price of $22.65.

Phibro Animal Health (NASDAQ:PAHC) last announced its earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. As a group, sell-side analysts anticipate that Phibro Animal Health will post 1.95 EPS for the current year.

Phibro Animal Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th were issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 2.21%. The ex-dividend date was Wednesday, March 5th. Phibro Animal Health’s dividend payout ratio is presently 100.00%.

Hedge Funds Weigh In On Phibro Animal Health

Several institutional investors have recently bought and sold shares of the company. Mackenzie Financial Corp acquired a new stake in shares of Phibro Animal Health in the 4th quarter worth $478,000. Public Employees Retirement System of Ohio acquired a new stake in Phibro Animal Health in the fourth quarter valued at about $323,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in Phibro Animal Health by 37.1% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 62,566 shares of the company’s stock valued at $1,314,000 after purchasing an additional 16,917 shares in the last quarter. Virtus Fund Advisers LLC acquired a new position in Phibro Animal Health during the 4th quarter worth approximately $69,000. Finally, Virtus Investment Advisers Inc. raised its stake in shares of Phibro Animal Health by 103.4% during the 4th quarter. Virtus Investment Advisers Inc. now owns 49,504 shares of the company’s stock worth $1,040,000 after buying an additional 25,160 shares in the last quarter. 99.34% of the stock is owned by institutional investors and hedge funds.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.